agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
1.280
+0.010 (0.79%)
Aug 29, 2025, 4:00 PM - Market closed
agilon health Stock Forecast
Stock Price Forecast
The 16 analysts that cover agilon health stock have a consensus rating of "Hold" and an average price target of $3.03, which forecasts a 136.72% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $7.50.
Price Target: $3.03 (+136.72%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 14 | 13 | 13 | 13 | 13 | 14 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 19 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy → Hold Downgrades $4 → $1.4 | Buy → Hold | Downgrades | $4 → $1.4 | +9.37% | Aug 20, 2025 |
| Jefferies | Jefferies | Hold Maintains $2.4 → $1.1 | Hold | Maintains | $2.4 → $1.1 | -14.06% | Aug 15, 2025 |
| Baird | Baird | Hold Maintains $5 → $1 | Hold | Maintains | $5 → $1 | -21.88% | Aug 14, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $1.5 | Strong Buy | Maintains | $4 → $1.5 | +17.19% | Aug 6, 2025 |
| Barclays | Barclays | Sell Maintains $3 → $1.5 | Sell | Maintains | $3 → $1.5 | +17.19% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
5.88B
from 6.06B
Decreased by -2.91%
Revenue Next Year
6.30B
from 5.88B
Increased by 7.04%
EPS This Year
-0.65
from -0.63
EPS Next Year
-0.39
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3B | 7.5B | |||
| Avg | 5.9B | 6.3B | |||
| Low | 5.6B | 5.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.3% | 27.4% | |||
| Avg | -2.9% | 7.0% | |||
| Low | -7.7% | -4.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.49 | -0.22 | ||
| Avg | -0.65 | -0.39 | ||
| Low | -0.87 | -0.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.